p62/SQSTM1 通过清除泛素化蛋白参与顺铂耐药的人卵巢癌细胞。
p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins.
机构信息
Department of Pathophysiology, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130021, PR China.
出版信息
Eur J Cancer. 2011 Jul;47(10):1585-94. doi: 10.1016/j.ejca.2011.01.019. Epub 2011 Mar 1.
Mechanisms of cisplatin resistance in cancer cells are not fully understood. Here, we show a critical role for the ubiquitin-binding protein p62/SQSTM1 in cisplatin resistance in human ovarian cancer cells (HOCCs). Specifically, we found that cisplatin-resistant SKOV3/DDP cells express much higher levels of p62 than do cisplatin-sensitive SKOV3 cells. The protein p62 binds ubiquitinated proteins for transport to autophagic degradation, reducing apoptosis induced by endoplasmic reticulum (ER) stress in SKOV3/DDP cells. Knockdown of p62 or inhibition of autophagy using 3-methyladenine resensitises SKOV3/DDP cells to cisplatin. Collectively, our data indicate that p62 acts as a receptor or adaptor for autophagic degradation of ubiquitinated proteins, and plays an important role in preventing ER stress-induced apoptosis, leading to cisplatin resistance in HOCCs.
癌细胞中顺铂耐药的机制尚不完全清楚。在这里,我们表明泛素结合蛋白 p62/SQSTM1 在人卵巢癌细胞(HOCCs)中的顺铂耐药中起关键作用。具体来说,我们发现顺铂耐药的 SKOV3/DDP 细胞比顺铂敏感的 SKOV3 细胞表达更高水平的 p62。蛋白 p62 结合泛素化蛋白进行运输到自噬降解,减少内质网(ER)应激诱导的 SKOV3/DDP 细胞凋亡。p62 的敲低或使用 3-甲基腺嘌呤抑制自噬使 SKOV3/DDP 细胞对顺铂敏感。总之,我们的数据表明 p62 作为泛素化蛋白自噬降解的受体或衔接蛋白发挥作用,在防止 ER 应激诱导的细胞凋亡中起重要作用,导致 HOCCs 中的顺铂耐药。